Literature DB >> 16877408

The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice.

Takashi Ota1, Makoto Aihara, Tadashiro Saeki, Shuh Narumiya, Makoto Araie.   

Abstract

PURPOSE: To determine the role of prostanoid EP receptors in the intraocular pressure (IOP)-lowering effect of prostaglandin analogues in EP receptor-deficient mice.
METHODS: Animals were bred and acclimatized in a 12-hour light-dark cycle. The diurnal IOP variation was measured by a microneedle method in EP1, EP2, and EP3 receptor-deficient mice (EP1KO, EP2KO and EP3KO) and in their wild-type (WT) background strain. IOP was measured in each mouse at night 3 hours after application of latanoprost, travoprost (0.004%), bimatoprost (0.03%), or unoprostone (0.12%). In WT and EP3KO mice, the effects of preapplication of diclofenac Na on drug-induced IOP reduction were examined.
RESULTS: Baseline IOPs were the same for all strains. Higher baseline IOPs were observed at night. Maximum IOP reduction occurred in WT mice 3 hours after latanoprost application during the day and night. Three hours after instillation at night, each of the four drugs lowered IOP significantly in WT, EP1KO, and EP2KO mice, whereas EP3KO a significantly lesser effect was induced by latanoprost, travoprost, and bimatoprost. Preapplication of diclofenac Na significantly attenuated drug-induced IOP reduction in WT but not in EP3KO mice.
CONCLUSIONS: Deficiency of EP receptors had no effect on physiological IOP. EP1 and EP2 receptors are not involved in prostaglandin analogue-induced IOP reduction, whereas EP3 receptors may play a role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877408     DOI: 10.1167/iovs.06-0100

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

Review 1.  Effects of prostaglandin analogues on aqueous humor outflow pathways.

Authors:  Nelson S Winkler; Michael P Fautsch
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-20       Impact factor: 2.671

Review 2.  Prostanoid receptor agonists for glaucoma treatment.

Authors:  Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2021-07-06       Impact factor: 2.447

3.  Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.

Authors:  Sudharshan Hariharan; Mukul Minocha; Gyan P Mishra; Dhananjay Pal; Rohit Krishna; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2009-12       Impact factor: 2.671

4.  Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists.

Authors:  Isamu Sugimoto; Tohru Kambe; Tomotaka Okino; Tetsuo Obitsu; Nobukazu Ohta; Taihei Nishiyama; Akihiro Kinoshita; Taku Fujimoto; Hiromu Egashira; Shinsaku Yamane; Satoshi Shuto; Kousuke Tani; Toru Maruyama
Journal:  ACS Med Chem Lett       Date:  2016-12-13       Impact factor: 4.345

5.  The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice.

Authors:  Takashi Ota; Makoto Aihara; Tadashiro Saeki; Shuh Narumiya; Makoto Araie
Journal:  Br J Ophthalmol       Date:  2006-11-23       Impact factor: 4.638

Review 6.  Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review.

Authors:  Raul E Ruiz-Lozano; Jimena Alamillo-Velazquez; Gustavo Ortiz-Morales; Lucas A Garza-Garza; Manuel E Quiroga-Garza; Carlos Alvarez-Guzman; Alejandro Rodriguez-Garcia
Journal:  Int Ophthalmol       Date:  2022-08-13       Impact factor: 2.029

7.  Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.

Authors:  B'Ann True Gabelt; Elizabeth A Hennes; Mark A Bendel; Chase E Constant; Mehmet Okka; Paul L Kaufman
Journal:  J Ocul Pharmacol Ther       Date:  2009-02       Impact factor: 2.671

Review 8.  Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.

Authors:  Carol B Toris; B'Ann T Gabelt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

Review 9.  Latanoprost in the treatment of glaucoma.

Authors:  Albert Alm
Journal:  Clin Ophthalmol       Date:  2014-09-26

10.  A model for the easy assessment of pressure-dependent damage to retinal ganglion cells using cyan fluorescent protein-expressing transgenic mice.

Authors:  Hidekazu Tsuruga; Hiroshi Murata; Makoto Araie; Makoto Aihara
Journal:  Mol Vis       Date:  2012-10-05       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.